• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Merck, BMS, AbbVie blockbusters will rule pharma sales in 2025: report

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 04, 2019 at 01:02: PM
via AbbVie's Humira has been topping pharma's sales charts, but in a few years it'll be passed by Merck's Keytruda and several other meds, a GlobalData forecast shows. Also in the top 10 are Bristol and Pfizer's Eliquis, Celgene's Revlimid, and BMS' Opdivo.

article source
 




Top Bottom
Back
Quote